CBIV Nominated for 2026 Prix Galien USA Award
Cross-Border Impact Ventures has been nominated by The Galien Foundation for the 2026 Prix Galien USA Award in the "Incubators, Accelerators and Equity" category.
Cross-Border Impact Ventures Announces US$58 Million First Close of Women’s and Children’s Health Technology Fund II
Second fund builds on successful portfolio, strategic exit, and measurable global health impact as institutional investors double down on women’s and children’s health innovation.
Cross-Border Impact Ventures Wins Best HealthTech Investment Company 2024 – Canada Award
Wealth & Finance International chooses Cross-Border Impact Ventures as the recipient of the Best HealthTech Investment Company 2024 - Canada Award.
Cross-Border Impact Ventures: Investing In Transformative Health Companies To Meet The Needs Of Women And Children
Pulse 2.0 interviews Managing Partner Annie Theriault about CBIV's mission to be the preferred investor for transformative health technology companies with the potential to meet the needs of women, children, and adolescents across global markets.
Samsung Medison to Acquire French AI Ultrasound Startup Sonio for $92.7M
Samsung Medison plans to acquire Sonio, a Paris-based startup that makes AI-powered software for ultrasound workflows, for about $92.7M USD.
Cross-Border Impact Ventures Surpasses $90M USD in Final Close to Back Women, Children-Focused HealthTech Startups
Two years after its launch, Toronto-based Cross-Border Impact Ventures (CBIV) has closed its first fund, securing over $90 million USD ($135 million CAD) in total commitments.
Contact Us
Cross-Border Impact Ventures
661 University Avenue, MaRs Centre, West Tower, Suite 1720, Toronto, ON M5G 1M1
